AimedBio logo

Public archive

AimedBio partners with Boehringer Ingelheim (26 Oct 2026)

Updated November 6, 2026

AimedBio partners with Boehringer Ingelheim on 26 October 2026. The agreement covers global.

Event data

Company
AimedBio
Partner Company
Boehringer Ingelheim
Partnership Type
commercial
Deal Scope
global
Products Involved
BI 4060107
Strategic Purpose
advance ADC into clinical development for solid tumors
Sector
Biotechnology
Country
South Korea
Announcement Date
2026-10-26

Subscribers saw this 9 days earlier.

Source

businesswire.com